{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:35:09Z","timestamp":1785386109098,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.athplu.2021.11.002","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T12:27:18Z","timestamp":1637238438000},"page":"35-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Hypoglycemia-induced changes in complement pathways in type 2 diabetes"],"prefix":"10.1016","volume":"46","author":[{"given":"Abu Saleh Md","family":"Moin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9732-9798","authenticated-orcid":false,"given":"Manjula","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhame","family":"Diboun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Qaissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-3917","authenticated-orcid":false,"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.athplu.2021.11.002_bib1","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Diabetes Study","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.athplu.2021.11.002_bib2","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athplu.2021.11.002_bib3","doi-asserted-by":"crossref","first-page":"b5444","DOI":"10.1136\/bmj.b5444","article-title":"The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study","volume":"340","author":"Miller","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.athplu.2021.11.002_bib4","doi-asserted-by":"crossref","first-page":"b4909","DOI":"10.1136\/bmj.b4909","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study","volume":"340","author":"Bonds","year":"2010","journal-title":"BMJ"},{"issue":"40","key":"10.1016\/j.athplu.2021.11.002_bib5","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/eurheartj\/eht332","article-title":"Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial","volume":"34","author":"Investigators","year":"2013","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.athplu.2021.11.002_bib6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Investigators","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.athplu.2021.11.002_bib7","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.2337\/dc14-0908","article-title":"Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the Edinburgh Type 2 Diabetes Study","volume":"37","author":"Bedenis","year":"2014","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.athplu.2021.11.002_bib8","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.2009.496","article-title":"Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction","volume":"301","author":"Kosiborod","year":"2009","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.athplu.2021.11.002_bib9","doi-asserted-by":"crossref","first-page":"f4533","DOI":"10.1136\/bmj.f4533","article-title":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis","volume":"347","author":"Goto","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.athplu.2021.11.002_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/dc18-1144","article-title":"Effects of severe hypoglycemia on cardiovascular outcomes and death in the veterans Affairs diabetes trial","volume":"42","author":"Davis","year":"2019","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.athplu.2021.11.002_bib11","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Group","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.athplu.2021.11.002_bib12","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1210\/jc.2007-0933","article-title":"Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose","volume":"92","author":"Boden","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.athplu.2021.11.002_bib13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1538-7836.2006.01803.x","article-title":"Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients","volume":"4","author":"Seljeflot","year":"2006","journal-title":"J\u00a0Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.athplu.2021.11.002_bib14","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2337\/diacare.26.7.2181","article-title":"The platelet in diabetes: focus on prevention of ischemic events","volume":"26","author":"Colwell","year":"2003","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.athplu.2021.11.002_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0038-1657180","article-title":"Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects","volume":"47","author":"Dalsgaard-Nielsen","year":"1982","journal-title":"Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.athplu.2021.11.002_bib16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/diab.35.7.818","article-title":"Studies on mechanisms involved in hypoglycemia-induced platelet activation","volume":"35","author":"Trovati","year":"1986","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.athplu.2021.11.002_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jcp.32.5.434","article-title":"Platelet aggregation studies during transient hypoglycaemia: a potential method for evaluating platelet function","volume":"32","author":"Hutton","year":"1979","journal-title":"J\u00a0Clin Pathol"},{"issue":"4","key":"10.1016\/j.athplu.2021.11.002_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.metabol.2008.10.018","article-title":"Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects","volume":"58","author":"Razavi Nematollahi","year":"2009","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.athplu.2021.11.002_bib19","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc10-0013","article-title":"Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes","volume":"33","author":"Wright","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.athplu.2021.11.002_bib20","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/dc09-0354","article-title":"Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals","volume":"33","author":"Gogitidze Joy","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.athplu.2021.11.002_bib21","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2337\/dc10-0503","article-title":"Proinflammatory and prothrombotic effects of hypoglycemia","volume":"33","author":"Dandona","year":"2010","journal-title":"Diabetes Care"},{"issue":"6098","key":"10.1016\/j.athplu.2021.11.002_bib22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1126\/science.337.6098.1034","article-title":"Immunology. The new view of complement","volume":"337","author":"Leslie","year":"2012","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.athplu.2021.11.002_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.athplu.2021.11.002_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v11.i1.1","article-title":"Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus","volume":"11","author":"Shim","year":"2020","journal-title":"World J Diabetes"},{"issue":"7","key":"10.1016\/j.athplu.2021.11.002_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1373\/clinchem.2018.287581","article-title":"Complement C3 and risk of diabetic microvascular disease: a cohort study of 95202 individuals from the general population","volume":"64","author":"Rasmussen","year":"2018","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.athplu.2021.11.002_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/dmrr.2380","article-title":"Complement-mediated chronic inflammation is associated with diabetic microvascular complication","volume":"29","author":"Fujita","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"10.1016\/j.athplu.2021.11.002_bib27","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc11-1642","article-title":"Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial","volume":"35","author":"Mellbin","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.athplu.2021.11.002_bib28","article-title":"Hypoglycaemia in type 2 diabetes exacerbates amyloid-related proteins associated with dementia","author":"Moin","year":"2020","journal-title":"Diabetes Obes Metabol"},{"issue":"3","key":"10.1016\/j.athplu.2021.11.002_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/dom.13548","article-title":"Effects of acute insulin-induced hypoglycaemia on endothelial microparticles in adults with and without type 2 diabetes","volume":"21","author":"Al-Qaissi","year":"2019","journal-title":"Diabetes Obes Metabol"},{"issue":"3","key":"10.1016\/j.athplu.2021.11.002_bib30","first-page":"182","article-title":"Hypoglycemia unawareness in patients with insulin-treated diabetes-mellitus","volume":"12","author":"Hepburn","year":"1991","journal-title":"Saudi Med J"},{"issue":"10","key":"10.1016\/j.athplu.2021.11.002_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026332","article-title":"From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay","volume":"6","author":"Kraemer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.athplu.2021.11.002_bib32","doi-asserted-by":"crossref","first-page":"14357","DOI":"10.1038\/ncomms14357","article-title":"Connecting genetic risk to disease end points through the human blood plasma proteome","volume":"8","author":"Suhre","year":"2017","journal-title":"Nat Commun"},{"issue":"23\u201324","key":"10.1016\/j.athplu.2021.11.002_bib33","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/sim.4780132309","article-title":"Internal pilot studies for estimating sample size","volume":"13","author":"Birkett","year":"1994","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.athplu.2021.11.002_bib34","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1038\/s41598-020-61531-z","article-title":"Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects","volume":"10","author":"Kahal","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.athplu.2021.11.002_bib35","first-page":"265","article-title":"Elevation of complement components in diabetes mellitus","volume":"6","author":"McMillan","year":"1980","journal-title":"Diabete Metab"},{"issue":"1","key":"10.1016\/j.athplu.2021.11.002_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.bmb.a072175","article-title":"The molecular genetics and polymorphism of C2 and factor B","volume":"43","author":"Campbell","year":"1987","journal-title":"Br Med Bull"},{"issue":"28","key":"10.1016\/j.athplu.2021.11.002_bib37","doi-asserted-by":"crossref","first-page":"15280","DOI":"10.1016\/S0021-9258(18)95732-7","article-title":"gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes","volume":"260","author":"Strunk","year":"1985","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.athplu.2021.11.002_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/dc11-1483","article-title":"Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes","volume":"35","author":"Somani","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.athplu.2021.11.002_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.117.09242","article-title":"Complement factor B is a determinant of both metabolic and cardiovascular features of metabolic syndrome","author":"Coan","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.athplu.2021.11.002_bib40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/db09-0700","article-title":"Complement factor H is expressed in adipose tissue in association with insulin resistance","volume":"59","author":"Moreno-Navarrete","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.athplu.2021.11.002_bib41","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1160\/th15-05-0439","article-title":"The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes. The CODAM study","volume":"115","author":"Hertle","year":"2016","journal-title":"Thromb Haemostasis"},{"issue":"3","key":"10.1016\/j.athplu.2021.11.002_bib42","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ahj.2006.03.007","article-title":"Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma","volume":"152","author":"Donahue","year":"2006","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.athplu.2021.11.002_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12016-014-8453-8","article-title":"Vasculitides and the complement system: a comprehensive review","volume":"49","author":"Chimenti","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/j.athplu.2021.11.002_bib44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1191\/0961203304lu1080oa","article-title":"Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients","volume":"13","author":"Ramos-Casals","year":"2004","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.athplu.2021.11.002_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23205","article-title":"The early predictive role of complement C3 and C4 in patients with acute pancreatitis","volume":"34","author":"Zhang","year":"2020","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"7","key":"10.1016\/j.athplu.2021.11.002_bib46","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/bjs.1800670716","article-title":"Predictive value of serum complement (C3) in renal allograft rejection","volume":"67","author":"Kumar","year":"1980","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.athplu.2021.11.002_bib47","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2337\/dc18-0050","article-title":"Prolonged prothrombotic effects of antecedent hypoglycemia in individuals with type 2 diabetes","volume":"41","author":"Chow","year":"2018","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.athplu.2021.11.002_bib48","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","article-title":"Complement in immune and inflammatory disorders: pathophysiological mechanisms","volume":"190","author":"Ricklin","year":"2013","journal-title":"J\u00a0Immunol"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266708952100047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266708952100047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:44:11Z","timestamp":1763023451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266708952100047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":48,"alternative-id":["S266708952100047X"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2021.11.002","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoglycemia-induced changes in complement pathways in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2021.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}